Schizophrenia drug says goodbye to dopamine

Research output: Contribution to journalShort surveypeer-review

Abstract

A drug that activates glutamate receptors offers promise for a new class of anti-psychotic therapeutics and sheds light on the pathophysiology of this devastating disease (pages 1102-1107).

Original languageEnglish (US)
Pages (from-to)1018-1019
Number of pages2
JournalNature medicine
Volume13
Issue number9
DOIs
StatePublished - Sep 2007
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Schizophrenia drug says goodbye to dopamine'. Together they form a unique fingerprint.

Cite this